Amylyx Pharmaceuticals, Inc. (AMLX) Net Margin
- 2024-12-31: Net Margin 5646.02%.
- 2024-09-30: Net Margin -17476.92%.
- 2024-06-30: Net Margin 7106.55%.
- 2024-03-31: Net Margin -134.01%.
Complete source-backed net margin history.
- Available history
- 2021-09-30 to 2024-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | 5646.02% |
| 2024-09-30 | -17476.92% |
| 2024-06-30 | 7106.55% |
| 2024-03-31 | -134.01% |
| 2023-12-31 | 4.36% |
| 2023-09-30 | 20.35% |
| 2023-06-30 | 22.47% |
| 2023-03-31 | 2.20% |
| 2022-12-31 | -195.13% |
| 2022-09-30 | -15581.45% |
| 2021-09-30 | -8120.00% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -345.36% |
| 2023-12-31 | 12.94% |
| 2022-12-31 | -892.38% |
| 2021-12-31 | -30852.98% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |